login
  Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page
 

Download past and current PDFs issues




 
1 - 20 of 35   Items
Cardiovascular News Issue 35 - September 2014
Cardiovascular News Issue 35 - September 2014
download now
Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -Fractional flow reserve is safe and feasible in NSTEMI patients -Sanjit Jolly: TASTE -Tim Fischell: Renal denervation -Profile: Sunil Rao
Cardiovascular News Issue 35 - September 2014 US Edition
Cardiovascular News Issue 35 - September 2014 US Edition
download now
Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -Fractional flow reserve is safe and feasible in NSTEMI patients -Sanjit Jolly: TASTE -Tim Fischell: Renal denervation -Profile: Sunil Rao
Cardiovascular News Issue 34 - August 2014
Cardiovascular News Issue 34 - August 2014
download now
Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No incidences of severe paravalvular leak with next-generation TAVI devices -Robert Byrne: drug-coated balloons -Ziyad M Hijazi: Congenital conditions -Profile: Azeem Latib
Cardiovascular News Issue 34 - August 2014 US Edition
Cardiovascular News Issue 34 - August 2014 US Edition
download now
Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No incidences of severe paravalvular leak with next-generation TAVI devices -Robert Byrne: drug-coated balloons -Ziyad M Hijazi: Congenital conditions -Profile: Azeem Latib
Cardiovascular News Issue 33 - May 2014 US Edition
Cardiovascular News Issue 33 - May 2014 US Edition
download now
Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year survival is significantly better with self-expanding TAVI device than with surgery - "Interventional cardiology is losing more than 50% of the talent pool" - profile: David J Cohen
Cardiovascular News Issue 33 - May 2014
Cardiovascular News Issue 33 - May 2014
download now
Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year survival is significantly better with self-expanding TAVI device than with surgery - "Interventional cardiology is losing more than 50% of the talent pool" - profile: David J Cohen
Cardiovascular News Issue 32 - February 2014
Cardiovascular News Issue 32 - February 2014
download now
Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by Ronald P Caputo -Profile: Ashok Seth
Cardiovascular News Issue 32 - February 2014 US Edition
Cardiovascular News Issue 32 - February 2014 US Edition
download now
Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by Ronald P Caputo -Profile: Ashok Seth
Cardiovascular News Issue 31 - October 2013
Cardiovascular News Issue 31 - October 2013
download now
Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be feasible when bilateral approach is not possible -Profile: Thomas F Luscher
Cardiovascular News Issue 31 - October 2013 US Edition
Cardiovascular News Issue 31 - October 2013 US Edition
download now
Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be feasible when bilateral approach is not possible -Profile: Thomas F Luscher
Cardiovascular News issue 30 - August 2013
Cardiovascular News issue 30 - August 2013
download now
Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in renal denervation by Erwin Blessing -Profile: Chaim Lotan
Cardiovascular News issue 30 - August 2013 US edition
Cardiovascular News issue 30 - August 2013 US edition
download now
Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in renal denervation by Erwin Blessing -Profile: Chaim Lotan
Cardiovascular News issue 29 - May 2013
Cardiovascular News issue 29 - May 2013
download now
Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce heart damage during angioplasty. Profile: Morton Kern
Cardiovascular News issue 29 - May 2013 US edition
Cardiovascular News issue 29 - May 2013 US edition
download now
Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce heart damage during angioplasty. Profile: Morton Kern
Cardiovascular News Issue 28 - February 2013
Cardiovascular News Issue 28 - February 2013
download now
Highlights: -RESPECT seen as positive despite failure to meet endpoint -Stent type may affect antiplatelet therapy duration -TAVI complications by Max Baghai -Profile: Stefan D Anker
Cardiovascular News Issue 28 - February 2013 US Edition
Cardiovascular News Issue 28 - February 2013 US Edition
download now
Highlights: -RESPECT seen as positive despite failure to meet endpoint -Stent type may affect antiplatelet therapy duration -TAVI complications by Max Baghai -Profile: Stefan D Anker
Cardiovascular News Issue 27 - October 2012
Cardiovascular News Issue 27 - October 2012
download now
Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with in-hospital mortality comparable to surgery -Profile: David Holmes
Cardiovascular News Issue 27 - October 2012 US edition
Cardiovascular News Issue 27 - October 2012 US edition
download now
Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with in-hospital mortality comparable to surgery -Profile: David Holmes
Cardiovascular News Issue 26 - August 2012 US edition
Cardiovascular News Issue 26 - August 2012 US edition
download now
Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy alone -Alain Cribier: 10 years of TAVI -Profile: Bernard Chevalier
Cardiovascular News Issue 26 - August 2012
Cardiovascular News Issue 26 - August 2012
download now
Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy alone -Alain Cribier: 10 years of TAVI -Profile: Bernard Chevalier
Cardiovascular News Issue 25 - May 2012
Cardiovascular News Issue 25 - May 2012
download now
Highlights: -TAVI as effective as surgery in high-risk patients at two years -Sustained blood pressure reduction achieved with renal denervation out to three years -MRI and arrhytmias by James White -Profile: John Ormiston

Most popular


Medtronic launches Resolute Onyx drug-eluting stent following CE mark approval
Tuesday, 04 Nov 2014
Medtronic has undertaken the international launch of its Resolute Onyx drug-eluting stent following the receipt of CE mark approval. The first live patient implant of the Resolute Onyx occurred ... Medtronic launches Resolute Onyx drug-eluting stent following CE mark approval

New data from EVOLVE clinical programme demonstrate SYNERGY success
Friday, 21 Nov 2014
In the first successful US pivotal trial of a bioabsorbable polymer stent, the Boston Scientific everolimus-eluting bioabsorbable polymer platinum chromium coronary stent system met its primary ... New data from EVOLVE clinical programme demonstrate SYNERGY success

Combined mitral valve repair and CABG do not provide additional benefits
Friday, 28 Nov 2014
The combination of coronary artery bypass grafting (CABG) and mitral valve repair is not associated with additional benefits compared with CABG alone in patients with multivessel disease and moderate ... Combined mitral valve repair and CABG do not provide additional benefits

Features


Performing TAVI in a hybrid operating room
Wednesday, 10 Dec 2014
Daniel O’ Hair believes hybrid ORs may provide distinct advantages for complex TAVI cases. He speaks to Cardiovascular News about his experience of performing TAVI in a hybrid OR. Performing TAVI in a hybrid operating room

First transcatheter tricuspid valve replacement performed in the USA
Friday, 28 Nov 2014
A team at Henry Ford Hospital, Detroit, USA, has successfully performed the first transcatheter tricuspid valve replacement surgery in the USA. First transcatheter tricuspid valve replacement performed in the USA

Profiles


Sunil Rao
Thursday, 23 Oct 2014
Sunil Rao speaks to Cardiovascular News about his career highlights, including his research into ... Sunil Rao

Azeem Latib
Wednesday, 24 Sep 2014
Azeem Latib (senior interventional cardiologist, San Raffaele Hospital and EMO-GVM Centro Cuore C... Azeem Latib

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions